Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue

Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385(25):2361–76.

Article  CAS  PubMed  Google Scholar 

Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379–91.

Article  CAS  PubMed  Google Scholar 

Maron BA, Abman SH. Pulmonary arterial hypertension: diagnosis, treatment, and novel advances. Case Rep. 2021;203(12):1472–87.

CAS  Google Scholar 

Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.

Article  PubMed  PubMed Central  Google Scholar 

Thompson AAR, Lawrie A. Targeting vascular remodeling to treat pulmonary arterial hypertension. Trends Mol Med. 2017;23(1):31–45.

Article  CAS  PubMed  Google Scholar 

Coons JC, Pogue K, Kolodziej AR, Hirsch GA, George MP. Pulmonary arterial hypertension: a pharmacotherapeutic update. Curr Cardiol Rep. 2019;21(11):141.

Article  PubMed  Google Scholar 

Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5–14.

Article  PubMed  Google Scholar 

Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–36.

Article  CAS  PubMed  Google Scholar 

Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339–47.

Article  PubMed  Google Scholar 

Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74(13):2345–60.

Article  CAS  PubMed  Google Scholar 

He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke. Front Neurosci. 2021;15: 641157.

Article  PubMed  PubMed Central  Google Scholar 

Dierick F, Solinc J, Bignard J, Soubrier F, Nadaud S. Progenitor/stem cells in vascular remodeling during pulmonary arterial hypertension. Cells. 2021;10(6):1338.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Lu W, Ouyang H, Chen Y, Zhang C, Luo X, Li M, Shu J, Zheng Q, Chen H, et al. Transplantation of mesenchymal stem cells attenuates pulmonary hypertension by normalizing the endothelial-to-mesenchymal transition. Am J Respir Cell Mol Biol. 2020;62(1):49–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muhammad SA, Abbas AY, Saidu Y, Fakurazi S, Bilbis LS. Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: a systematic review and meta-analysis. Biochimie. 2020;168:156–68.

Article  CAS  PubMed  Google Scholar 

Pan X, Suzuki N, Hirano I, Yamazaki S, Minegishi N, Yamamoto M. Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS ONE. 2011;6(10):e25839.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rathod DB, Salahudeen AK. Nonerythropoietic properties of erythropoietin: implication for tissue protection. J Investig Med. 2011;59(7):1083–5.

Article  CAS  PubMed  Google Scholar 

Sun LL, Lei FR, Jiang XD, Du XL, Xiao L, Li WD, Li XQ. LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway. Aging. 2020;12(5):4506–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Z, Lian W, He Y, Zhang C, Lin G. Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids. Arch Toxicol. 2023;97(3):819–29.

Article  CAS  PubMed  Google Scholar 

Han XP, Zhang FQ, Tan XS, Liu L, Ma WX, Ou-Yang HF, Wu CG. EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model. J Cell Biochem. 2018;119(1):1008–16.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Zhou S, Hu JM, Chen H, Liu D, Li M, Guo Y, Fan LP, Li LY, Liu YG, et al. Preliminary study of bone marrow-derived mesenchymal stem cells pretreatment with erythropoietin in preventing acute rejection after rat renal transplantation. Transpl Proc. 2018;50(10):3873–80.

Article  CAS  Google Scholar 

Sun C, Zhang S, Wang J, Jiang W, Xin Q, Chen X, Zhang Z, Luan Y. EPO enhances the protective effects of MSCs in experimental hyperoxia-induced neonatal mice by promoting angiogenesis. Aging. 2019;11(8):2477–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai C, Wu Y, Yang L, Xiang Y, Zhu N, Zhao H, Hu W, Lv L, Zeng C. Sodium selenite attenuates balloon injury-induced and monocrotaline-induced vascular remodeling in rats. Front Pharmacol. 2021;12: 618493.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang ZH, Lu Y, Luan Y, Zhao JJ. Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension. Exp Ther Med. 2012;4(5):839–43.

Article  PubMed  PubMed Central  Google Scholar 

Luan Y, Zhang X, Kong F, Cheng GH, Qi TG, Zhang ZH. Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol. 2012;14(4):432–7.

Article  CAS  PubMed  Google Scholar 

Liu N, Tian J, Wang W, Cheng J, Hu D, Zhang J. Effect and mechanism of erythropoietin on mesenchymal stem cell proliferation in vitro under the acute kidney injury microenvironment. Exp Biol Med (Maywood). 2011;236(9):1093–9.

Article  CAS  PubMed  Google Scholar 

Tsiftsoglou AS. Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (mscs): implications in regenerative medicine. Cells. 2021;10(8):2140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang ZH, Zhang SJ, Zhao HP, Li FF. Erythropoietin promotes the differentiation of fetal neural stem cells into glial cells via the erythropoietin receptor-β common receptor/Syne-1/H3K9me3 pathway. CNS Neurosci Ther. 2022;28(9):1351–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allegra A, Galasso A, Siracusano L, Aloisi C, Corica F, Laganà A, Frisina N, Buemi M. Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock. Nephron. 1996;74(2):431–2.

Article  CAS  PubMed  Google Scholar 

Allegra A, Giacobbe MS, Corvaia E, Cinquegrani M, Corvaja E, Giorgianni G, Buemi M. Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale. Nephrol Dial Transplant. 2005;20(12):2866–7.

Article  CAS  PubMed  Google Scholar 

Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H, Karibe A, Minegishi N, Suzuki N, Yamamoto M, et al. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation. 2006;113(11):1442–50.

Article  CAS  PubMed  Google Scholar 

Hasegawa J, Wagner KF, Karp D, Li D, Shibata J, Heringlake M, Bahlmann L, Depping R, Fandrey J, Schmucker P, et al. Altered pulmonary vascular reactivity in mice with excessive erythrocytosis. Am J Respir Crit Care Med. 2004;169(7):829–35.

Article  PubMed  Google Scholar 

Weissmann N, Manz D, Buchspies D, Keller S, Mehling T, Voswinckel R, Quanz K, Ghofrani HA, Schermuly RT, Fink L, et al. Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost. 2005;94(3):630–8.

CAS  PubMed  Google Scholar 

Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2017;367(3):643–9.

Article  PubMed  Google Scholar 

Leopold JA, Maron BA. Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension. Int J Mol Sci. 2016;17(5):761.

Article  PubMed  PubMed Central  Google Scholar 

Kovacs L, Cao Y, Han W, Meadows L, Kovacs-Kasa A, Kondrikov D, Verin AD, Barman SA, Dong Z, Huo Y, et al. PFKFB3 in smooth muscle promotes vascular remodeling in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2019;200(5):617–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie J, Hu D, Niu L, Qu S, Wang S, Liu S. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats. J Huazhong Univ Scie Tehnol Medi Sci. 2012;32(6):810–7.

Article  CAS 

留言 (0)

沒有登入
gif